[{"address1": "700 Quince Orchard Road", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 268 2000", "website": "https://www.novavax.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 952, "companyOfficers": [{"maxAge": 1, "name": "Mr. John Charles Jacobs M.B.A.", "age": 57, "title": "President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 1550611, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James Patrick Kelly C.F.A.", "age": 58, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 880849, "exercisedValue": 0, "unexercisedValue": 19825}, {"maxAge": 1, "name": "Mr. Mark J. Casey Esq.", "age": 61, "title": "Executive VP, Chief Legal Officer & Corporate Secretary", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 997654, "exercisedValue": 0, "unexercisedValue": 89347}, {"maxAge": 1, "name": "Ms. Elaine  O'Hara", "age": 56, "title": "Executive VP & Chief Strategy Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 991316, "exercisedValue": 0, "unexercisedValue": 35053}, {"maxAge": 1, "name": "Mr. Richard P. Crowley", "age": 67, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Troy  Morgan Esq., J.D.", "age": 53, "title": "Senior VP, Deputy General Counsel & Chief Compliance Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erika S. Trahan", "title": "Associate Director of Investor & Public Relations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian J. Watkins", "age": 61, "title": "Executive VP & Chief Human Resources Officer", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Henrietta  Ukwu FACP FRAPS, M.D.", "age": 57, "title": "Executive VP & Chief Regulatory Officer", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert  Walker M.D.", "title": "Senior VP & Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 6, "shareHolderRightsRisk": 5, "overallRisk": 5, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://www.novavax.com/go.cfm?do=Stock.GetQuote", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.43, "open": 8.33, "dayLow": 8.27, "dayHigh": 8.535, "regularMarketPreviousClose": 8.43, "regularMarketOpen": 8.33, "regularMarketDayLow": 8.27, "regularMarketDayHigh": 8.535, "payoutRatio": 0.0, "beta": 2.746, "trailingPE": 3.7837837, "forwardPE": -52.5, "volume": 3376063, "regularMarketVolume": 3376063, "averageVolume": 6000723, "averageVolume10days": 3390650, "averageDailyVolume10Day": 3390650, "bid": 8.36, "ask": 8.46, "bidSize": 4, "askSize": 10, "marketCap": 1364341760, "fiftyTwoWeekLow": 5.01, "fiftyTwoWeekHigh": 11.55, "allTimeHigh": 331.68, "allTimeLow": 3.53, "priceToSalesTrailing12Months": 1.2647808, "fiftyDayAverage": 8.388, "twoHundredDayAverage": 7.61395, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 980527808, "profitMargins": 0.39196998, "floatShares": 136489405, "sharesOutstanding": 162421645, "sharesShort": 45828036, "sharesShortPriorMonth": 44723391, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.28219998, "heldPercentInsiders": 0.08748, "heldPercentInstitutions": 0.5852, "shortRatio": 10.03, "shortPercentOfFloat": 0.2832, "impliedSharesOutstanding": 163001722, "bookValue": 0.232, "priceToBook": 36.206898, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "earningsQuarterlyGrowth": -0.344, "netIncomeToCommon": 422824000, "trailingEps": 2.22, "forwardEps": -0.16, "lastSplitFactor": "1:20", "lastSplitDate": 1557446400, "enterpriseToRevenue": 0.909, "enterpriseToEbitda": 2.406, "52WeekChange": -0.078947365, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 8.4, "targetHighPrice": 25.0, "targetLowPrice": 6.0, "targetMeanPrice": 12.6125, "targetMedianPrice": 9.45, "recommendationMean": 2.625, "recommendationKey": "hold", "numberOfAnalystOpinions": 8, "totalCash": 612304000, "totalCashPerShare": 3.77, "ebitda": 407505984, "totalDebt": 228490000, "quickRatio": 2.155, "currentRatio": 2.363, "totalRevenue": 1078717952, "debtToEquity": 607.282, "revenuePerShare": 6.705, "returnOnAssets": 0.14515, "grossProfits": 616860992, "freeCashflow": -627235008, "operatingCashflow": -630940992, "earningsGrowth": -0.381, "revenueGrowth": -0.424, "grossMargins": 0.57185, "ebitdaMargins": 0.37777, "operatingMargins": 0.44169, "financialCurrency": "USD", "symbol": "NVAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Novavax, Inc.", "averageAnalystRating": "2.6 - Hold", "cryptoTradeable": false, "longName": "Novavax, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1761955171, "regularMarketTime": 1761940800, "exchange": "NMS", "messageBoardId": "finmb_350381", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "regularMarketChangePercent": -0.35588, "regularMarketPrice": 8.4, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 818173800000, "postMarketChangePercent": 0.0, "postMarketPrice": 8.4, "postMarketChange": 0.0, "regularMarketChange": -0.0300007, "regularMarketDayRange": "8.27 - 8.535", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 6000723, "fiftyTwoWeekLowChange": 3.3899994, "fiftyTwoWeekLowChangePercent": 0.67664653, "fiftyTwoWeekRange": "5.01 - 11.55", "fiftyTwoWeekHighChange": -3.1500006, "fiftyTwoWeekHighChangePercent": -0.2727273, "fiftyTwoWeekChangePercent": -7.8947363, "dividendDate": 1557446400, "earningsTimestamp": 1762432200, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 2.22, "epsForward": -0.16, "epsCurrentYear": 2.06538, "priceEpsCurrentYear": 4.0670476, "fiftyDayAverageChange": 0.012000084, "fiftyDayAverageChangePercent": 0.0014306252, "twoHundredDayAverageChange": 0.78604984, "twoHundredDayAverageChangePercent": 0.10323812, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "market": "us_market", "esgPopulated": false, "displayName": "Novavax", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]